19 /100
LOW RISK
Score updated Apr 13, 2026

ANTX

AN2 Therapeutics, Inc. — Stock Dilution Tracker

Track ANTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track ANTX — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
40
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ANTX.
🔔 Track ANTX — Get forecast alerts →
💹 Market Data
Market Cap$106.77M
Shares Outstanding35.95M
Float16.95M
Cash$58.00M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 6.9% shares (2025Q4 vs prior)
37 institutional holders · 9.05M shares
#1 Almitas Capital LLC 1.48M shares
#2 VANGUARD GROUP INC 1.08M shares
#3 BANK OF AMERICA CORP /DE/ 770.6K shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest564.3K
Days to Cover1.4
% of Float3.3%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Jun 30, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2022
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 23, 2026
4 INSIDER TRANSACTION Mar 23, 2026
Full SEC filing analysis available with free account
📰 Recent News
No recent news
Track ANTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ANTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required